A look at second-generation bioresorbable scaffolds: BIOSOLVE II and BIOSOLVE III

Summary

Bioresorbable scaffolds continued to take centre stage at EuroPCR 2017. M. Haude introduces us to two trials with results from a newer-generation device with a unique magnesium alloy backbone. How does this backbone differ from PLLA? Is the absorption time different? What were the results in terms of safety, and the all-important consideration of stent thrombosis? Does this device handle differently from other bioresorbable devices, such as in trackability? And what about these 2-year results, now out of the timeframe of DAPT use? Learn what has been achieved – and what still needs to be done – here…